Based on our bioinformatics analysis (Figure 3C) and experimental validation (Figure 9A), we confirmed that ESM1 could accelerate OC carcinogenesis (proliferation, apoptosis, metastasis, and angiogenesis) via the Akt/mTOR pathway, which has been demonstrated to be a significant cancer-promoting signaling pathway. Here, AKT1 is linked to cancer.